First Known Report of mcr-Harboring Enterobacteriaceae in the Dominican Republic

Int J Environ Res Public Health. 2023 Mar 14;20(6):5123. doi: 10.3390/ijerph20065123.

Abstract

Colistin is a last-resort antibiotic used to treat infections caused by multidrug-resistant Gram-negative bacteria. People with a history of travel to the Dominican Republic have become sick with pathogenic bacteria carrying the mobile colistin resistance gene, mcr-1, during and after traveling. This investigation aimed to identify mcr genes in Enterobacteriaceae isolated from food animal sources in the Dominican Republic. Three hundred and eleven samples were tested, from which 1354 bacterial isolates were obtained. Real-time PCR tests showed that 70.7% (220 out of 311) of the samples and 3.2% (44 out of 1354) of the isolates tested positive for the mcr gene. All RT-PCR presumptive mcr-positive isolates (n = 44) and a subset (n = 133) of RT-PCR presumptive mcr-negative isolates were subjected to whole-genome sequencing. WGS analysis showed that 39 isolates carried the mcr gene, with 37 confirmed as positive through RT-PCR and two as negative. Further, all of the mcr-positive genomes were identified as Escherichia coli and all contained a IncX4 plasmid replicon. Resistant determinants for other antibiotics important for human health were found in almost all isolates carrying mcr genes.

Keywords: Enterobacteriaceae; Escherichia coli; IncX4; antimicrobial resistance; colistin resistance; mcr genes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Colistin / pharmacology
  • Dominican Republic / epidemiology
  • Drug Resistance, Bacterial / genetics
  • Enterobacteriaceae*
  • Escherichia coli
  • Escherichia coli Proteins* / genetics
  • Humans
  • Microbial Sensitivity Tests
  • Plasmids

Substances

  • Colistin
  • Anti-Bacterial Agents
  • Escherichia coli Proteins
  • MCR-1 protein, E coli

Grants and funding

This research was funded by the Center for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS), under Grant number 75D30118C02911.